CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates innovative immunotherapy delivery methods for cancer treatment, particularly lung cancer. It explores using genetically modified bacteria to deliver therapies directly to tumor sites, enhancing treatment effectiveness.
Immunotherapeutic strategies are powerful weapons in combating malignancies.
However, only a minority of patients benefit from this therapeutic modality, as tumours develop mechanisms of immune escape and suppression and uptake of (antibody-based) agents in tumors is limited.
The urgency of investigating novel strategic approaches is dictated by the high incidence and mortality rates of cancer worldwide.
Lung cancer, in particular, is the leading cancer with respect to incidence and mortality (1…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
